January 20, 2026

Integra LifeSciences Holdings C (IART) Growth Potential: Exploring a 24.9% Upside

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the healthcare sector specializing in medical devices, presents a compelling case for investors looking for growth potential within a challenging..

Investor Outlook: Novavax, Inc. (NVAX) Shows Potential 59.66% Upside Despite Challenges

Novavax, Inc. (NVAX), a pioneering player in the biotechnology sector, continues to capture the interest of investors with its innovative vaccine offerings. Headquartered in Gaithersburg, Maryland, Novavax has positioned itself..

Viridian Therapeutics, Inc. (VRDN) Investor Outlook: Unpacking a Remarkable 81,958% Revenue Growth in the Biotech Sector

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a notable player in the biotechnology sector, is catching the eye of investors with its staggering revenue growth of 81,958.10%. Specializing in the development of..

The Pennant Group, Inc. (PNTG) Investor Outlook: Analyzing a 28.64% Potential Upside in Healthcare

In the ever-evolving landscape of healthcare services, The Pennant Group, Inc. (NASDAQ: PNTG) emerges as a noteworthy player, delivering an impressive potential upside of 28.64% according to recent analyst ratings...

Arrowhead Pharmaceuticals, Inc. (ARWR)

⚠️ No article content returned.

..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 22.48% Potential Upside for Investors

U.S. Physical Therapy, Inc. (NYSE: USPH) is capturing the attention of investors with a compelling potential upside of 22.48%, according to the latest analyst ratings. As a key player in..

PACS Group, Inc. (PACS) Stock Analysis: Strong Revenue Growth and Analyst Optimism Signal a 14% Upside Potential

PACS Group, Inc. (NASDAQ: PACS), a leader in the healthcare sector, focuses on operating skilled nursing and assisted living facilities across the United States. Despite market fluctuations, the company has..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: A Biotech Player with a 12.23% Upside Potential

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a Canadian biotech firm focused on autoimmune diseases, presents an intriguing opportunity for investors seeking exposure in the healthcare sector. With a market capitalization of..

CONMED Corporation (CNMD) Stock Analysis: Exploring a 16.43% Upside Potential for Investors

CONMED Corporation (NASDAQ: CNMD), a key player in the healthcare sector with a focus on medical devices, offers investors an intriguing opportunity. With a market cap of $1.29 billion, this..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Exploring a 19.31% Potential Upside in Healthcare

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) stands as a prominent player in the medical care facilities sector, offering a diversified range of home healthcare services across the United States. With..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Unlocking a 35% Upside Potential

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is making waves in the biotechnology sector with its innovative focus on cellular metabolism. Headquartered in Cambridge, Massachusetts, Agios is renowned for its development of..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Unveiling a Potential 362% Upside in Cutting-Edge Immunotherapy

Janux Therapeutics, Inc. (NASDAQ: JANX), a promising player in the biotechnology sector, is captivating investor attention with its innovative approach to cancer treatment. With a market capitalization of $827.63 million,..

Innoviva, Inc. (INVA) Stock Report: Uncovering a 67% Upside Potential in the Biotechnology Sector

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, is currently capturing investor attention with its promising growth trajectory and significant potential upside. Based in Burlingame, California, Innoviva..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a Potential 177.99% Upside

Opko Health, Inc. (NASDAQ: OPK), a key player in the healthcare sector, is stirring interest among investors with its compelling growth potential. Despite its recent challenges, the diagnostics and pharmaceuticals..

GoodRx Holdings Inc. (GDRX) Stock Analysis: Assessing a Potential 76.84% Upside in Health Information Services

GoodRx Holdings, Inc. (NASDAQ: GDRX) represents a unique player in the healthcare sector, particularly within the Health Information Services industry. As a company providing consumers with the ability to compare..

MannKind Corporation (MNKD) Stock Analysis: Unpacking an 84.47% Potential Upside Amid Biotech Innovation

MannKind Corporation (NASDAQ: MNKD) has carved a niche in the healthcare sector, with a focus on developing and commercializing therapeutic products for endocrine and orphan lung diseases. Based in Danbury,..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Exploring a 40.75% Potential Upside

Dynavax Technologies Corporation (NASDAQ: DVAX) is a prominent player in the healthcare sector, specifically within the drug manufacturing industry, focusing on specialty and generic products. Based in the United States,..

Omnicell, Inc. (OMCL) Stock Analysis: Exploring an 8.87% Potential Upside in the Healthcare Sector

Omnicell, Inc. (NASDAQ: OMCL) is a noteworthy player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $2.32 billion, Omnicell is making strides..

Harrow, Inc. (HROW) Stock Analysis: A Strong Buy with 47.44% Potential Upside

Investors interested in Harrow, Inc. (NASDAQ: HROW) will find plenty to be optimistic about as the company positions itself as a formidable player in the healthcare sector. Specializing in the..

Pulse Biosciences, Inc (PLSE) Investor Outlook: Exploring a 54% Potential Upside

Pulse Biosciences, Inc (NASDAQ: PLSE) is capturing the attention of investors with its innovative approach to bioelectric medicine. Operating within the healthcare sector and specializing in medical instruments and supplies,..

Search

Funds

January 20, 2026

Search

Funds

January 20, 2026

FTSE 100

Funds